Parkisonism induced by high‐dose cytosine arabinoside
Identifieur interne : 003A39 ( Istex/Curation ); précédent : 003A38; suivant : 003A40Parkisonism induced by high‐dose cytosine arabinoside
Auteurs : Luque [États-Unis] ; John B. Selhorst [États-Unis] ; Paul Petruska [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1987.
English descriptors
Abstract
We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The durg was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian durgs and fortunately remitted completely within 12 weeks.
Url:
DOI: 10.1002/mds.870020309
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003A39
Links to Exploration step
ISTEX:AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkisonism induced by high‐dose cytosine arabinoside</title><author><name sortKey="Luque" sort="Luque" uniqKey="Luque" last="Luque">Luque</name><affiliation wicri:level="2"><mods:affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Missouri (État)</region></placeName><wicri:cityArea>Department of Neurology, Saint Louis University School of Medicine, St. Louis</wicri:cityArea></affiliation></author><author><name sortKey="Selhorst, John B" sort="Selhorst, John B" uniqKey="Selhorst J" first="John B." last="Selhorst">John B. Selhorst</name><affiliation wicri:level="2"><mods:affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Missouri (État)</region></placeName><wicri:cityArea>Department of Neurology, Saint Louis University School of Medicine, St. Louis</wicri:cityArea></affiliation></author><author><name sortKey="Petruska, Paul" sort="Petruska, Paul" uniqKey="Petruska P" first="Paul" last="Petruska">Paul Petruska</name><affiliation wicri:level="2"><mods:affiliation>Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Missouri (État)</region></placeName><wicri:cityArea>Internal Medicine, Saint Louis University School of Medicine, St. Louis</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88</idno><date when="1987" year="1987">1987</date><idno type="doi">10.1002/mds.870020309</idno><idno type="url">https://api.istex.fr/document/AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003A39</idno><idno type="wicri:Area/Istex/Curation">003A39</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Parkisonism induced by high‐dose cytosine arabinoside</title><author><name sortKey="Luque" sort="Luque" uniqKey="Luque" last="Luque">Luque</name><affiliation wicri:level="2"><mods:affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Missouri (État)</region></placeName><wicri:cityArea>Department of Neurology, Saint Louis University School of Medicine, St. Louis</wicri:cityArea></affiliation></author><author><name sortKey="Selhorst, John B" sort="Selhorst, John B" uniqKey="Selhorst J" first="John B." last="Selhorst">John B. Selhorst</name><affiliation wicri:level="2"><mods:affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Missouri (État)</region></placeName><wicri:cityArea>Department of Neurology, Saint Louis University School of Medicine, St. Louis</wicri:cityArea></affiliation></author><author><name sortKey="Petruska, Paul" sort="Petruska, Paul" uniqKey="Petruska P" first="Paul" last="Petruska">Paul Petruska</name><affiliation wicri:level="2"><mods:affiliation>Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Missouri (État)</region></placeName><wicri:cityArea>Internal Medicine, Saint Louis University School of Medicine, St. Louis</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1987">1987</date><biblScope unit="vol">2</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="219">219</biblScope><biblScope unit="page" to="222">222</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88</idno><idno type="DOI">10.1002/mds.870020309</idno><idno type="ArticleID">MDS870020309</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cytosine arabinoside</term><term>Myelogenous leukemia</term><term>Parkinsonism</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The durg was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian durgs and fortunately remitted completely within 12 weeks.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A39 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 003A39 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88
|texte= Parkisonism induced by high‐dose cytosine arabinoside
}}
| This area was generated with Dilib version V0.6.23. |  |